IP Library Assignment 048270/0813
Patent Assignment
Reel/Frame 048270/0813

Security Interest

Recorded: 2019-02-07 Pages: 23
Assignors
APTEVO THERAPEUTICS INC.
Executed: 2019-02-07
APTEVO BIOTHERAPEUTICS INC.
Executed: 2019-02-07
Assignee
MIDCAP FINANCIAL TRUST, AS AGENT
7255 WOODMONT AVENUE, SUITE 200, BETHESDA, MARYLAND, 20814
Covered Properties (34)
CD123 Binding Proteins and Related Compositions and Methods
Binding Constructs and Methods for Use Thereof
Patent: 7,829,084 →
Application: 10/627,556 →
Publication: US 2005/0136049
Binding Domain-Immunoglobulin Fusion Proteins
Patent: 8,106,161 →
Application: 11/088,693 →
Publication: US 2005/0202028
CD37 Immunotherapeutics and Uses Thereof
Application: 11/493,132 →
Publication: US 2007/0059306
Materials and Methods for Improved Immunoglycoproteins
Patent: 7,846,434 →
Application: 12/082,497 →
Publication: US 2009/0041765
Single-Chain Multivalent Binding Proteins with Effector Function
Patent: 8,409,577 →
Application: 12/304,562 →
Publication: US 2011/0033483
CD37 Immunotherapeutic and Combination with Bifunctional Chemotherapeutic Thereof
Patent: 9,101,609 →
Application: 12/422,780 →
Publication: US 2009/0274692
Binding Domain-Immunoglobulin Fusion Proteins
Patent: 8,147,835 →
Application: 12/541,062 →
Publication: US 2010/0034820
CD37 Immunotherapeutics and Uses Thereof
Patent: 8,333,966 →
Application: 12/678,857 →
Publication: US 2011/0171208
Binding Domain-Immunoglobulin Fusion Proteins
Patent: 8,188,237 →
Application: 12/901,295 →
Publication: US 2011/0105729
Binding Domain-Immunoglobulin Fusion Proteins
Patent: 8,197,810 →
Application: 12/901,297 →
Publication: US 2011/0091461
Materials and Methods for Improved Immunoglycoproteins
Patent: 8,383,106 →
Application: 12/909,769 →
Publication: US 2011/0256125
CD86 Antagonist Multi-Target Binding Proteins
Patent: 9,493,564 →
Application: 13/122,383 →
Publication: US 2012/0100139
Binding Domain-Immunoglobulin Fusion Proteins
Patent: 8,853,366 →
Application: 13/396,147 →
Publication: US 2012/0213773
Binding Domain-Immunoglobulin Fusion Proteins
Patent: 9,005,612 →
Application: 13/451,641 →
Publication: US 2013/0142793
B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules
Application: 13/836,103 →
Publication: US 2014/0004117
CD3 Binding Polypeptides
Application: 14/395,689 →
Publication: US 2015/0232557
Method of Producing Recombinant Vitamin K Dependent Proteins
Patent: 9,587,008 →
Application: 14/475,881 →
Publication: US 2014/0369994
Recombinant Vitamin K Dependent Proteins with High Sialic Acid Content and Methods of Preparing Same
Application: 14/860,042 →
Publication: US 2016/0244738
TCR Complex Immunotherapeutics
Application: 15/040,744 →
Publication: US 2017/0008960
Cell Line-Based Redirected T-Cell Cytotoxicity Assay
Application: 15/126,922 →
Publication: US 2017/0089885
CD86 Antagonist Multi-Target Binding Proteins
Application: 15/281,441 →
Publication: US 2017/0015747
Compositions and Methods for Combination Therapy with Prostate-Specific Membrane Antigen Binding Proteins
Application: 15/550,143 →
Publication: US 2018/0022819
Prostate-Specific Membrane Antigen Binding Proteins and Related Compositions and Methods
Patent: 9,782,478 →
Application: 15/585,921 →
Publication: US 2017/0306045
Single-Chain Multivalent Binding Proteins with Effector Function
Application: 15/617,833 →
Publication: US 2018/0118823
Prostate-Specific Membrane Antigen Binding Proteins and Related Compositions and Methods
Application: 15/699,474 →
Publication: US 2018/0100021
CD3 Binding Polypeptides
Application: 15/761,499 →
Publication: US 2018/0273622
Heterodimer Binding Proteins and Uses Thereof
Application: 15/802,636 →
Publication: US 2018/0273642
Method of Producing Biologically Active Vitamin K Dependent Proteins by Recombinant Methods
Application: 15/875,373 →
Publication: US 2019/0032101
Methods of treatment of CD123 overexpressing disorders
Application: 15/933,324 →
Publication: US 2019/0071513
Stabilized Factor Ix Formulations Containing Trehalose
Application: 16/028,736 →
Publication: US 2019/0167797
Oncofetal Antigen Binding Proteins and Related Compositions and Methods
Application: 16/041,309 →
Publication: US 2019/0016816
B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules
Application: 16/172,096 →
Publication: US 2019/0290755
Oncofetal Antigen Binding Proteins and Related Compositions and Methods
Application: 62/648,072 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 12, 2004
From: LEDBETTER, JEFFREY A.; LEDBETTER, MARTHA S.; THOMPSON, PETER A.
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 015319/0819 →
Certificate of Amendment of Genecraft May 26, 2006
From: GENECRAFT, INC.
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 017936/0723 →
Assignment of Assignor's Interest Sep 20, 2006
From: GROSMAIRE, LAURA S.; HAYDEN-LEDBETTER, MARTHA S.; LEDBETTER, JEFFREY A.; THOMPSON, PETER A.
To: TRUBION PHARMACEUTICALS
Reel/Frame 018276/0958 →
Assignment of Assignor's Interest Dec 3, 2008
From: THOMPSON, PETER ARMSTRONG; BAUM, PETER ROBERT; ESPLING, ERIK STEPHEN
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 021920/0279 →
Assignment of Assignor's Interest May 20, 2009
From: THOMPSON, PETER ARMSTRONG; LEDBETTER, JEFFREY A.; HAYDEN-LEDBETTER, MARTHA SUSAN; GROSMAIRE, LAURA SUE
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 022710/0969 →
Assignment of Assignor's Interest May 20, 2009
From: TCHISTIAKOVA, LIOUDMILA; FOLLETTIE, MAXIMILLIAN T.; CALABRO, VALERIE; SCHULLER, ALWIN
To: WYETH
Reel/Frame 022710/0981 →
Assignment of Assignor's Interest Jun 30, 2009
From: TAN, PHILLIP; SIMON, SANDY A.; CERVENY, CHARLES G.; NILSSON, CHRISTY ANNE
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 022894/0701 →
Assignment of Assignor's Interest Jul 14, 2009
From: THOMPSON, PETER ARMSTRONG; LEDBETTER, JEFFREY A.; HAYDEN-LEDBETTER, MARTHA SUSAN; GROSMAIRE, LAURA SUE
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 022952/0441 →
Assignment of Assignor's Interest Apr 21, 2010
From: TAN, PHILLIP; SIMON, SANDY ALEXANDER; CERVENY, CHARLES G.; NILSSON, CHRISTY ANNE
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 024267/0845 →
Assignment of Assignor's Interest Nov 12, 2010
From: BAUM, PETER ROBERT; ESPLING, ERIK STEPHEN; THOMPSON, PETER ARMSTRONG
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 025356/0526 →
Merger Dec 21, 2010
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 025541/0845 →
Merger Dec 21, 2010
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 025532/0711 →
Merger Dec 21, 2010
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 025532/0740 →
Merger Dec 21, 2010
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 025532/0733 →
Merger Dec 21, 2010
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 025548/0844 →
Merger Dec 21, 2010
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 025547/0272 →
Merger Dec 21, 2010
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 025546/0959 →
Merger Dec 21, 2010
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 025532/0841 →
Merger Dec 21, 2010
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 025546/0670 →
Merger Dec 21, 2010
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 025532/0652 →
Merger Dec 21, 2010
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 025546/0686 →
Assignment of Assignor's Interest Jun 2, 2011
From: THOMPSON, PETER A.; BAUM, PETER R.; TAN, PHILIP; BLANKENSHIP, JOHN W.
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 026380/0087 →
Merger Jun 24, 2011
From: TRUBION PHARMACEUTICALS, INC.
To: EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Reel/Frame 026493/0188 →
Change of Name Nov 10, 2011
From: GENECRAFT, INC.
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 027212/0182 →
Assignment of Assignor's Interest Nov 10, 2011
From: LEDBETTER, JEFFREY A.; HAYDEN-LEDBETTER, MARTHA S.
To: GENECRAFT, INC.
Reel/Frame 027206/0544 →